Position in IMTX
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$160,116
-$10,740 QoQ
Shares Held
16,272
0.0% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2024
8 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Pale Fire Capital SE holds $46,388,436 across 25 Biotechnology names. IMTX ranks #25 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MLYS |
Mineralys Therapeutics, Inc.
|
365,626 | $9,904,808 | |
| 2 | GERN |
Geron Corp
|
4,888,304 | $7,283,572 | |
| 3 | KURA |
Kura Oncology, Inc.
|
857,474 | $6,971,263 | |
| 4 | SNDX |
Syndax Pharmaceuticals Inc
|
284,460 | $6,644,985 | |
| 5 | RGNX |
REGENXBIO Inc.
|
493,726 | $4,137,423 | |
| 6 | GUTS |
Fractyl Health, Inc.
|
5,921,045 | $2,711,838 | |
| 7 | HRTX |
Heron Therapeutics, Inc. /De/
|
2,716,328 | $2,173,062 | |
| 8 | SGMT |
Sagimet Biosciences Inc.
|
221,875 | $1,159,296 |
All Filings in IMTX
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $160,116 | 16,272 | Shares | Defined | 2026-05-14 | |
| 2025-12-31 | $170,856 | 16,272 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $291,980 | 34,270 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $184,372 | 34,270 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $154,557 | 34,270 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $223,694 | 31,462 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $279,111 | 24,462 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $133,908 | 11,524 | Shares | Defined | 2024-08-13 | |
| No filing history on record for this holder in this stock. | ||||||